ProNAi Therapeutics (DNAI) Misses Q3 EPS by 21c
Tweet
Share
E-mailGet Alerts DNAI Hot Sheet
Join SI Premium – FREE
ProNAi Therapeutics (NASDAQ: DNAI) reported Q3 EPS of ($0.50), $0.21 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
